Page 1 of 4
New Research Initiative Launch
Orbicure is proud to announce the launch of our groundbreaking research initiative focused on developing innovative solutions for chronic conditions. This multi-year project represents our commitment to advancing pharmaceutical science.
The initiative will focus on three key areas:
- Advanced neurological treatments for neurodegenerative diseases
- Next-generation cardiovascular therapies with enhanced efficacy
- Innovative immunology solutions for autoimmune conditions
Our dedicated team of researchers, including leading scientists from Pakistan and international collaborators, will work at our state-of-the-art research facility in Islamabad. The project is expected to yield significant breakthroughs within the next 24 months.
Investment: This initiative represents a $5M investment in pharmaceutical research and development, demonstrating Orbicure's commitment to advancing healthcare solutions.
Page 2 of 4
State-of-the-Art Facility
We are excited to announce the completion of our new 50,000 square foot research and manufacturing facility in Islamabad. This facility represents the pinnacle of pharmaceutical innovation in Pakistan.
The facility features:
Advanced Labs
Equipped with cutting-edge analytical instruments and research equipment for pharmaceutical development.
Manufacturing Wing
GMP-certified production area with automated systems for precision manufacturing of pharmaceutical products.
Quality Control
Dedicated QC laboratories ensuring every product meets international quality standards before release.
The facility is designed with sustainability in mind, featuring energy-efficient systems and environmentally responsible waste management processes. It represents Orbicure's commitment to both innovation and corporate responsibility.
Page 3 of 4
Strategic Partnerships
Orbicure is proud to announce new strategic partnerships with leading international research institutions and healthcare organizations. These collaborations will accelerate our research and expand our global reach.
Our Key Partners:
UIH
United Institute of Health Sciences
Collaborating on neurological research and clinical trials
GPRC
Global Pharmaceutical Research Council
Joint research initiatives and knowledge exchange programs
MHC
MediCare Health Consortium
Distribution partnership for international market expansion
These partnerships will enable Orbicure to leverage global expertise while contributing Pakistani innovation to the international pharmaceutical community.
Page 4 of 4
Future Outlook & Commitment
As we look to the future, Orbicure remains committed to our core values of innovation, quality, and patient-centered care. Our strategic roadmap outlines our vision for the next five years.
2026-2030 Strategic Goals:
1
Launched our New Innovative Product
Developing novel pharmaceutical solutions for unmet medical needs in Cardiology
2
Expand to New Markets
Establishing presence in more markets across pakistan with our premium pharmaceutical solutions.
3
Cardiovascular Support
Specially formulated to support heart health and improve overall cardiovascular function through traditional herbal ingredients.
4
Quality Manufacturing
Produced by Orbit Naturals in Pakistan, a DR&F licensed herbal and nutraceutical company following strict quality standards.
Our Commitment: Orbicure is dedicated to advancing pharmaceutical science while maintaining the highest ethical standards. We believe that quality healthcare is a fundamental right, and we're committed to making innovative treatments accessible to those who need them most.